Clinical Trial Update: ETNA-MS Device Validation Study

View source ↗

Summary

The ETNA-MS device validation study sponsored by Innodem Neurosciences has completed for multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Innodem Neurosciences | Conditions: Multiple Sclerosis | Status: COMPLETED